Loading company…
Riskpilot
← Back to search
Sign in
Get full access
A05 Diagnostics AB
AB
In liquidation
Org 5592614001
Other human health activities · NACE 8690
Est. 2020
12 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
SEK 157M
-75% vs 2021
EBITDA margin
33.7%
-85% vs 2021
Equity ratio
98.1%
Financial strength
Net profit 2022
SEK 38,5M
-86% vs 2021
EBITDA — year on year
SEK millions
455M
341M
228M
114M
0M
364M
2021
53M
-85%
2022
Key figures
Annual report 2022
Revenue
SEK 157M
-75%
EBITDA
SEK 52,9M
-85%
Net profit
SEK 38,5M
-86%
Total assets
SEK 43,7M
-86%
Equity
SEK 42,8M
-85%
Employees
12
—
Company information
Legal name
A05 Diagnostics AB
Org number
5592614001
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
1 juli 2020
Share capital
SEK 25 000
Employees
12 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva utveckling av och utföra medicinsk diagnostik samt därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities
Companies in
All Sweden companies
Revenue
SEK millions
0M
180M
359M
539M
719M
625M
2021
157M
2022
EBITDA
SEK millions
0M
105M
209M
314M
419M
364M
2021
53M
2022
Income statement
SEK thousands
Item
2021
2022
Revenue
624 920
157 002
Staff expenses
—
—
EBITDA
363 636
52 902
Depreciation & amort.
−1 673
−3 868
EBIT
361 963
49 034
Net financials
—
−14
Profit before tax
361 963
49 020
Tax
−77 667
−10 516
Net profit
284 296
38 504
Balance sheet
SEK thousands
Item
2021
2022
Total assets
323 072
43 651
Equity
284 321
42 824
Long-term debt
0
0
Short-term debt
38 752
827
Total debt
38 752
827
Financial ratios
5-year trend
EBITDA margin
33.7%
This company
15.8%
Market median
+113% vs market
2021
2022
Equity ratio
98.1%
This company
38.2%
Market median
+157% vs market
2021
2022
Return on equity
89.9%
This company
18.4%
Market median
+389% vs market
2021
2022
Net profit margin
24.5%
This company
8.1%
Market median
+202% vs market
2021
2022
Asset turnover
3.60×
This company
1.12×
Market median
+221% vs market
2021
2022
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2021
2022
Annual reports & filings
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
MM
Monika Margareta Wannholm
Chief Auditor
Chief Auditor
2020
KJ
Karl Johan Fredrik Winnerblad
Liquidator
Liquidator
2020
Former (1)
KM
Karin Marianne Hansson
Chief Executive Officer
Chief Executive Officer
2020 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Former (2)
OA
Olov Andreas Forslund
Deputy Board Member
2020 – 2020
LP
Lennart Patrik Tobias Andersson
Board of Directors
2020 – 2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of A05 Diagnostics AB also hold positions in
0
other companies.
Person
Role here
Other companies
Monika Margareta Wannholm
Chief Auditor
0 companies
Karin Marianne Hansson
Chief Executive Officer
0 companies
Karl Johan Fredrik Winnerblad
Liquidator
0 companies
Olov Andreas Forslund
Deputy Board Member
0 companies
Lennart Patrik Tobias Andersson
Board of Directors
0 companies